Nanosphere Health Sciences (FRA:2CG) Tariff Resilience Score: 4/10 (As of Jul. 09, 2026)


What is Nanosphere Health Sciences Tariff Resilience Score?

Nanosphere Health Sciences FRA:2CG Tariff Resilience Score is 4 as of Jul. 09, 2026. Among 1,368 Biotechnology companies, Nanosphere Health Sciences ranks better than 52.49% on this metric.

Nanosphere Health Sciences has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Nanosphere Health Sciences has Nanosphere Health Sciences, operating in the health and wellness sector, faces tariff risks due to its reliance on imported raw materials. While it has some pricing power, shifts in trade policies could impact costs and supply chain efficiency.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Nanosphere Health Sciences might have Average Resilient.

Nanosphere Health Sciences  (FRA:2CG) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Nanosphere Health Sciences Tariff Resilience Score Related Terms

FRA:2CG vs VRTX, REGN, ALNY: Tariff Resilience Score Comparison

For the Biotechnology subindustry, Nanosphere Health Sciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nanosphere Health Sciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's Tariff Resilience Score falls into.


What does a Tariff Resilience Score of 4 mean?
Nanosphere Health Sciences (FRA:2CG) has a Tariff Resilience Score of 4 as of Jul. 09, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Nanosphere Health Sciences ranks #650 out of 1368 companies in the Biotechnology industry, placing it in the top 47.5%.
Is Nanosphere Health Sciences' Tariff Resilience Score too high?
Nanosphere Health Sciences' current Tariff Resilience Score is 4. The Biotechnology industry median Tariff Resilience Score is 4.00. Nanosphere Health Sciences' value of 4 is 0% at this industry median. Based on the distribution chart, Nanosphere Health Sciences ranks #650 out of 1368 companies in the Biotechnology industry, which is above the industry midpoint.
How does Nanosphere Health Sciences' Tariff Resilience Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Nanosphere Health Sciences ranks #650 out of 1368 companies for Tariff Resilience Score. This puts Nanosphere Health Sciences in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. Nanosphere Health Sciences' value of 4 is 0% at this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,368 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nanosphere Health Sciences's current Tariff Resilience Score of 4 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nanosphere Health Sciences's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nanosphere Health Sciences stock overvalued right now?
Nanosphere Health Sciences (FRA:2CG) has a current Tariff Resilience Score of 4. The current Tariff Resilience Score is 4 and 0% at the Biotechnology industry median of 4.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Nanosphere Health Sciences (FRA:2CG), the current Tariff Resilience Score is 4 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nanosphere Health Sciences Business Description

Other Exchanges NSHSF:USANSHS:Canada
Address 605 Robson Street, c/o Suite 430, Vancouver, BC, CAN, V6B 5J3
Nanosphere Health Sciences Inc is a biotechnology company focused on providing next generation delivery of biologically active compounds through licensing and joint venture arrangements. The Company has developed and is commercializing its patented NanoSphere Delivery System, a nanotechnology platform for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals, and over-the-counter medications for the cannabis, pharmaceutical, and animal health industries. The NanoSphere Delivery System provides improved bioavailability, efficacy, and onset of effect over traditional delivery systems.